National Institute of Neurological Disorders and Stroke; Notice of Meeting, 12962-12963 [2021-04521]
Download as PDF
<![CDATA[
12962
Federal Register / Vol. 86, No. 42 / Friday, March 5, 2021 / Notices
Boulevard, Baltimore, MD 21224 (Virtual
Meeting).
Closed: May 06, 2021, 9:00 a.m. to 9:30
a.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institute on Aging,
Biomedical Research Center, 251 Bayview
Boulevard, Baltimore, MD 21224 (Virtual
Meeting).
Open: May 06, 2021, 9:30 a.m. to 11:30
a.m.
Agenda: Committee discussion, individual
presentations, laboratory overview.
Place: National Institute on Aging,
Biomedical Research Center, 251 Bayview
Boulevard, Baltimore, MD 21224 (Virtual
Meeting).
Closed: May 06, 2021, 11:30 a.m. to 1:30
p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institute on Aging,
Biomedical Research Center, 251 Bayview
Boulevard, Baltimore, MD 21224 (Virtual
Meeting).
Contact Person: Luigi Ferrucci, MD, Ph.D.,
Scientific Director, National Institute on
Aging, 251 Bayview Boulevard, Suite 100,
Room 4C225, Baltimore, MD 21224, 410–
558–8110, LF27Z@NIH.GOV.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS).
Dated: March 2, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–04593 Filed 3–4–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
jbell on DSKJLSW7X2PROD with NOTICES
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
VerDate Sep<11>2014
20:30 Mar 04, 2021
Jkt 253001
Emphasis Panel; Multidisciplinary Studies to
Improve Understanding of Influenza
Transmission (U19 Clinical Trial Optional).
Date: April 7–8, 2021.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G13B,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Yong Gao, Ph.D., Scientific
Review Officer, Scientific Review Program,
Division of Extramural Activities, National
Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers
Lane, Room 3G13B, Rockville, MD 20852,
(240) 669–5048, gaoL2@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: February 26, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–04512 Filed 3–4–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Sleep Disorders
Research Advisory Board.
Date: April 1, 2021.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: Summary of sleep and circadian
research activities at NIH and coordination
with other federal agencies; discussion of
NIH Sleep Disorders Research Plan Revision.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Blvd., Bethesda,
MD 20892 (Virtual Meeting).
Telephone Access: 1–646–828–7666
(Meeting ID: 161 330 2517 Passcode: 723398).
Virtual Access: https://nih.zoomgov.com
(Meeting ID: 161 330 2517, Passcode:
723398).
Contact Person: Marishka Brown, BS, MS,
Ph.D., Health Scientist Administrator,
National Center on Sleep Disorders Research,
National Heart, Lung, and Blood Institute,
National Institute of Health, 6701 Rockledge
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
Drive, Room 10183, Bethesda 20814–7952,
301–827–7822, marishka.brown@nih.gov.
Any member of the public interested in
presenting oral comments to the committee
may notify the Contact Person listed on this
notice at least 15 days in advance of the
meeting. Interested individuals and
representatives of organizations may submit
a letter of intent, a brief description of the
organization represented, and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee, presentations
may be limited to five minutes. Both printed
and electronic copies are requested for the
record. In addition, any interested person
may file written comments with the
committee by forwarding their statement to
the Contact Person listed on this notice. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
Information is also available on the
Institute’s/Center’s home page:
www.nhlbi.nih.gov/meetings/index.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: March 1, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–04524 Filed 3–4–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Neurological Disorders and Stroke
Council.
The meeting will be open to the
public. Individuals who plan to
participate and need special assistance,
such as sign language interpretation or
other reasonable accommodations,
should notify the Contact Person listed
below in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
E:\FR\FM\05MRN1.SGM
05MRN1
Federal Register / Vol. 86, No. 42 / Friday, March 5, 2021 / Notices
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council.
Date: May 26–27, 2021.
Open: May 26, 2021, 1:00 p.m. to 5:30 p.m.
Agenda: Report by the Director, NINDS;
Report by the Director, Division of
Extramural Activities; and Administrative
and Program Developments.
Open session will be videocast from this
link: https://videocast.nih.gov/
Closed: May 27, 2021, 1:00 p.m. to 5:30
p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Robert Finkelstein, Ph.D.,
Director of Extramural Research, National
Institute of Neurological Disorders and
Stroke, NIH, 6001 Executive Blvd., Suite
3309, MSC 9531, Bethesda, MD 20892, (301)
496–9248, finkelsr@ninds.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice at least 10 days in advance of the
meeting. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page:
www.ninds.nih.gov, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: February 26, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–04521 Filed 3–4–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
jbell on DSKJLSW7X2PROD with NOTICES
U.S. Customs and Border Protection
Notice of Issuance of Final
Determination Concerning Certain
Fixed and Portable Ceiling Lifts
This document provides
notice that U.S. Customs and Border
Protection (CBP) has issued a final
determination concerning the country of
origin of certain fixed and portable
ceiling lifts for healthcare purposes.
Based upon the facts presented, CBP has
concluded in the final determination
that the ceiling lifts would not to be
products of a foreign country or
instrumentality designated pursuant to
19 U.S.C. 2511(b) for purposes of U.S.
Government procurement.
SUMMARY:
The final determination was
issued on March 1, 2021. A copy of the
final determination is attached. Any
party-at-interest, as defined in 19 CFR
177.22(d), may seek judicial review of
this final determination no later than
April 5, 2021.
DATES:
FOR FURTHER INFORMATION CONTACT:
Albena Peters, Valuation and Special
Programs Branch, Regulations and
Rulings, Office of Trade, at (202) 325–
0321.
Notice is
hereby given that on March 1, 2021,
CBP issued a final determination
concerning the country of origin of fixed
and portable ceiling lifts for purposes of
Title III of the Trade Agreements Act of
1979. This final determination, HQ
H311763, was issued at the request of
the party-at-interest, under procedures
set forth at 19 CFR part 177, subpart B,
which implements Title III of the Trade
Agreements Act of 1979, as amended
(19 U.S.C. 2511–18). In the final
determination, CBP has concluded that,
based upon the facts presented, the
fixed and portable ceiling lifts would
not be products of a foreign country or
instrumentality designated pursuant to
19 U.S.C. 2511(b) for purposes of U.S.
Government procurement. Section
177.29, CBP Regulations (19 CFR
177.29), provides that a notice of final
determination shall be published in the
Federal Register within 60 days of the
date the final determination is issued.
Section 177.30, CBP Regulations (19
CFR 177.30), provides that any party-atinterest, as defined in 19 CFR 177.22(d),
may seek judicial review of a final
determination within 30 days of
publication of such determination in the
Federal Register.
SUPPLEMENTARY INFORMATION:
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: Notice of final determination.
AGENCY:
VerDate Sep<11>2014
20:30 Mar 04, 2021
Jkt 253001
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
12963
Dated: March 1, 2021.
Joanne R. Stump,
Acting Executive Director, Regulations and
Rulings,Office of Trade.
HQ H311763
March 1, 2021
OT:RR:CTF:VS H311763 AP
CATEGORY: Origin
F. Scott Galt, Partner
Armstrong Teasdale LLP
CIPP/E
7700 Forsyth Blvd., Suite 1800
St. Louis, MO
RE: U.S. Government Procurement; Title
III, Trade Agreements Act of 1979 (19
U.S.C. 2511); Subpart B, Part 177, CBP
Regulations; Country of Origin of Fixed
and Portable Ceiling Lifts
Dear Mr. Galt:
This is in response to your request of
June 12, 2020, on behalf of Span
America, Inc. (‘‘SA’’), for a final
determination concerning the country of
origin of certain fixed and portable
ceiling lifts for healthcare purposes.
This request is being sought because
your client wants to confirm eligibility
of the merchandise for U.S. government
procurement purposes under Title III of
the Trade Agreements Act of 1979
(‘‘TAA’’), as amended (19 U.S.C. 2511 et
seq.). SA is a party-at-interest within the
meaning of 19 CFR 177.22(d)(1) and
177.23(a).
FACTS:
SA is a U.S.-based manufacturer of
equipment and accessories for use in
medical facilities. Its corporate
headquarters and principal
manufacturing facility is located in
Greenville, South Carolina. SA
manufactures fixed and portable ceiling
lifts used in clinical or home settings to
safely lift and/or transport immobilized
individuals. SA produces two types of
ceiling lifts: The Savaria FL Fixed Lift
(‘‘fixed lift’’) and the Savaria PL Portable
Lift (‘‘portable lift’’). The fixed and
portable lifts are powered with
rechargeable lithium ion batteries. Users
can operate the lifts through the push
buttons located on the spreader bars or
a remote control. The fixed lift includes
buttons that control vertical and lateral
movement, while the portable lift only
contains buttons to raise and lower the
lift.
The fixed lift attaches to ceilingmounted track systems. Each fixed lift
consists of: (1) A motor unit base which
connects to the ceiling track system; (2)
a spreader bar that is a horizontal bar
with hooks on each end to which slings
are attached used to support a person’s
E:\FR\FM\05MRN1.SGM
05MRN1
]]>Agencies
[Federal Register Volume 86, Number 42 (Friday, March 5, 2021)]
[Notices]
[Pages 12962-12963]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-04521]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Advisory
Neurological Disorders and Stroke Council.
The meeting will be open to the public. Individuals who plan to
participate and need special assistance, such as sign language
interpretation or other reasonable accommodations, should notify the
Contact Person listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and
[[Page 12963]]
the discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: National Advisory Neurological Disorders and
Stroke Council.
Date: May 26-27, 2021.
Open: May 26, 2021, 1:00 p.m. to 5:30 p.m.
Agenda: Report by the Director, NINDS; Report by the Director,
Division of Extramural Activities; and Administrative and Program
Developments.
Open session will be videocast from this link: https://videocast.nih.gov/
Closed: May 27, 2021, 1:00 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
Contact Person: Robert Finkelstein, Ph.D., Director of
Extramural Research, National Institute of Neurological Disorders
and Stroke, NIH, 6001 Executive Blvd., Suite 3309, MSC 9531,
Bethesda, MD 20892, (301) 496-9248, [email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice at least 10 days in advance of the meeting. The
statement should include the name, address, telephone number and
when applicable, the business or professional affiliation of the
interested person.
Information is also available on the Institute's/Center's home
page: www.ninds.nih.gov, where an agenda and any additional
information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS)
Dated: February 26, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-04521 Filed 3-4-21; 8:45 am]
BILLING CODE 4140-01-P
